Neuromuscular Electrical Stimulation in Foot and Ankle Surgery

NCT ID: NCT06370325

Last Updated: 2025-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-01

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot randomized controlled trial, wherein the intervention group will undergo NMES five days a week beginning three weeks postoperative and lasting for ten weeks. Both the control and intervention groups will start standard physical therapy six weeks postoperative. Primary outcome measure will be the isometric strength of the gastrocnemius muscle. The secondary outcomes will comprise subjective clinical evaluations (using the Lower Extremity Functional Scale \[LEFS\]), functional assessments such as the sit-to-stand test, 2-minute walk test, stair climb test and objective clinical evaluation using contralateral comparison of calf circumference.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ankle Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

Participants randomized to the intervention group will undergo neuromuscular electrical stimulation (NMES) five days a week beginning three weeks postoperative and lasting for ten weeks. The intervention group will begin standard physical therapy at six weeks postoperative.

Group Type EXPERIMENTAL

VPOD Wireless Tens Unit

Intervention Type PROCEDURE

The VPOD unit will deliver NMES to participants in the Intervention Group.

Physical Therapy

Intervention Type PROCEDURE

Physical therapy as per standard of care.

Biodex

Intervention Type DEVICE

Used to assess strength, endurance, power, and range of motion.

Control Group

Participants randomized to the control group will begin standard physical therapy at six weeks postoperative.

Group Type ACTIVE_COMPARATOR

Physical Therapy

Intervention Type PROCEDURE

Physical therapy as per standard of care.

Biodex

Intervention Type DEVICE

Used to assess strength, endurance, power, and range of motion.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VPOD Wireless Tens Unit

The VPOD unit will deliver NMES to participants in the Intervention Group.

Intervention Type PROCEDURE

Physical Therapy

Physical therapy as per standard of care.

Intervention Type PROCEDURE

Biodex

Used to assess strength, endurance, power, and range of motion.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Capable and willing to provide informed consent
* Undergoing a procedure that involves repairing an ankle fracture.

Exclusion Criteria

Patients with medical histories that include:

* Rheumatoid arthritis
* Connective tissue disorders
* Chronic corticosteroid use
* Implanted electrical devices
* Neurological disorders
* Non-ambulatory status
* Recent surgery (within the last 3 months) that is not related to the study
* Scheduled to undergo surgery in the near future
* Epilepsy
* Diagnosed with cancer
* Have suffered acute trauma or recently have had a surgical procedure (not related to the study)
* Have cardiac problems or cardiac disease
* Have an abdominal hernia
* Have venous thrombosis
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NYU Langone Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raymond J. Walls, MD

Role: PRINCIPAL_INVESTIGATOR

NYU Langone Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NYU Langone Health

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Raymond J. Walls, MD

Role: CONTACT

(917) 780-8720

Thelma Jimenez Mosquea, MD

Role: CONTACT

(347) 880-2254

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-00987

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.